Why the study?
Mechanical dispersion by STE was suggested as an arrhythmic risk marker, prompting evaluation of LV-GLS and mechanical dispersion in HCM and Anderson-Fabry disease cardiomyopathy and their association with ventricular arrhythmias.
Are speckle tracking echocardiography-derived parameters (LV-GLS and MD) associated with ventricular arrhythmias in patients with hypertrophic cardiomyopathies?
Are speckle tracking echocardiography-derived parameters (LV-GLS and MD) associated with ventricular arrhythmias in patients with hypertrophic cardiomyopathies?
Mechanical dispersion measured by speckle tracking echocardiography is associated with ventricular arrhythmias in patients with hypertrophic cardiomyopathies, suggesting its potential as a prognostic marker for arrhythmic risk.
MD may support arrhythmic risk stratification in HCM; hypothesis-generating and requires prospective validation.
Aims Hypertrophic cardiomyopathies (HCM) are caused in 30–60% of cases by mutations in cardiac sarcomere genes but can also be an expression of cardiac involvement in multi-systemic metabolic diseases, such as Anderson–Fabry disease (AFD). HCM entails a risk of sudden cardiac death (SCD) of 0.9%/year and is the most common cause of SCD in young adults. Recent studies suggested mechanical dispersion (MD) by speckle tracking echocardiography (STE) as an additional arrhythmic risk marker. The aim of the study was to evaluate left ventricle global longitudinal strain (LV-GLS) and MD, in patients with HCM or AFD cardiomyopathy, and the association with ventricular arrhythmias (V-AR). Methods and results We evaluated 40 patients with HCM, 57 with AFD (12 with LV hypertrophy and 45 without), and 40 healthy subjects, between January 2014 and June 2022. We performed a comprehensive echocardiographic study and analysed systolic and diastolic functions, LV-GLS, and MD. We also analysed V-AR, including ventricular fibrillation and sustained/non-sustained ventricular tachycardia, by Holter electrocardiogram (Holter-EKG), in a subset of hypertrophic patients. Data were analysed by unpaired Student t-test or chi-square/Fisher’s exact test as appropriate and binary logistic regression (SPSS Statistics ver.26). LV-GLS was significantly lower in the V-AR group compared with patients without V-AR (median −10.2% vs. −14%, P = 0.038); MD was significantly higher in the V-AR group (85.5 ms vs. 61.1 ms, P = 0.004). V-AR were found significantly associated with MD (OR, 1.030; 95% CI, 1.003–1.058; P = 0.03). Conclusions MD is a useful additional index in the evaluation of patients with HCM and may be a promising prognostic predictor of increased arrhythmic risk.
No takes yet. Share an insight, caveat, or question.
Faro et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: